Clinical Trials in Ulcerative Colitis: A Historical Perspective
Authors:
- Fernando MagroFernando Magro
- Laurent Peyrin-BirouletLaurent Peyrin-Biroulet
- the Clinical Trial Committee Clincom of the European Crohn’s and Colitis Organisation (ECCO)T(the Clinical Trial Committee Clincom of the European Crohn’s and Colitis Organisation (ECCO)
Open Access
- 25 April 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 9 (7) , 580-588
Abstract
The clinical trial landscape in ulcerative colitis has evolved significantly in recent decades. Study endpoints have been shifting from mere clinical response to mucosal healing. It has become clear that the choice of combined clinical and endoscopic outcome criteria leads to a reduction in placebo responses, especially when central reading of the endoscopic images is performed. Accumulating evidence suggests that histological remission yields better long-term outcomes for ulcerative colitis patients than mucosal healing alone, and clinical trials with prolonged follow-up will have to address whether histological remission should be the ultimate treatment goal in ulcerative colitis. In recent years there has also been increasing interest in the implementation of patient-reported outcomes in clinical practice and research, and the regulatory authorities have set up guidelines for the development of such outcomes. This paper aims to provide a comprehensive review of historical aspects of clinical trials in ulcerative colitis and to discuss challenges and perspectives for clinical trials in the near future. A thorough analysis of all available landmark literature (both original papers and reviews) on clinical trials in ulcerative colitis was performed.Keywords
This publication has 75 references indexed in Scilit:
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2013
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2012
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative ColitisGastroenterology, 2011
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort StudyGastroenterology, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Ulcerative colitis: definition, historical background, aetiology, diagnosis, naturel history and local complicationsPostgraduate Medical Journal, 1968
- A double blind controlled trial of prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitisGut, 1962
- Drug-induced Immunological ToleranceNature, 1959
- SIR ASTLEY COOPER, BART.The Lancet, 1824